Wed, November 24, 2021
Tue, November 23, 2021
Mon, November 22, 2021
Sun, November 21, 2021
Sat, November 20, 2021
Fri, November 19, 2021
Thu, November 18, 2021
Wed, November 17, 2021
Tue, November 16, 2021

David Lebowitz Maintained (ARQT) at Buy with Decreased Target to $35 on, Nov 19th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-35-on-nov-19th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lebowitz of Morgan Stanley, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Buy with Decreased Target from $50 to $35 on, Nov 19th, 2021.

David, nor any peers, have made any analyst calls on ARQT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources